Skip to main content
Clinical Trials/IRCT201612278170N10
IRCT201612278170N10
Completed
Phase 2

Comparison of the effect of topical ointment Myrtus Communis and anti-hemorrhoid on first and second grade hemorrhoid symptoms and the quality of life of women in post delivery period: a triple-blind controlled clinical trial

Vice President of Research Tabriz University Of Medical Sciences0 sites54 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
hemorrhoid.
Sponsor
Vice President of Research Tabriz University Of Medical Sciences
Enrollment
54
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Vice President of Research Tabriz University Of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Women have given birth for at least 4 weeks and up to 4 months from their delivery, either in the normal way of any cesarean section (including Nully Par and Multipar); women in post delivery period who have been diagnosed their hemorrhoids first and second degree with clinical symptoms and confirmed by the Surgeon General; women between 18\-40 years; Women in the postpartum period whose hemorrhoids are not caused by systemic diseases such as hypertension; hemorrhoid symptomsfor at least more than 7 days; The ability to read and write.
  • Exclusion criteria: Use of Systemic steroid Drugs and non\-steroidal anti\-inflammatory drugs and analgesics and anti\-hemorrhoid treatments (for a one month prior to the study) and the use of anticoagulant drugs; require surgical procedure for the treatment of hemorrhoids (a gastroenterologist confirmed by clinical testing and colonoscopy); women with problems such as abscesses, anorectal, fistula, tuberculosis, herpes, varicella, fungal infection (confirmed by clinical trials or colonoscopy); risk of gastrointestinal tract infectious inflammatory diseases or colorectal cancer (as the patient); The previous use of laser or the use of medication felebotonic to treat hemorrhoids a week before the study (as the patient); Delivery with vacuums or forceps and delivery of cesarean section with large ancision; the company in another intervention study.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials